Publication
Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs.
Authors not recorded
J Clin Invest2024PMID 38687617PMC11142739stubpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CIVIC-20260908-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
No abstract stored. Read on PubMed
Linked entities
Linked entities (3)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 3
- cancerMalignant Prostate Neoplasmcivic_curation1.00
- geneARcivic_curation1.00
- variantAR AR-V7civic_curation1.00
Curated evidence
Evidence citing this paper (1)
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 38687617
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| AR AR-V71 | ||||||||
| (oncogenic) | Malignant Prostate Neoplasm | Oncogenic | D | Supports Oncogenicity | 4 | accepted | EID12465To compare the activity of AR-V7 with that of full-length AR (AR-FL) lentiviral stable cell lines of castrate-resistant prostate cancer were generated that expressed doxycycline-regulated AR-V7 or AR-… (full text at CIViC) PMID 38687617 · Han et al., 2024 · Open in CIViC | civic |